Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice
Effect of peripheral cannabinoid receptor 1 (CB1R) blockade by AM6545 in the monosodium glutamate (MSG)-induced hypometabolic and hypothalamic obesity was observed, and the impact on intraperitoneal adipose tissue and adipokines was investigated. The MSG mice is characterized by excessive abdominal...
Saved in:
Main Authors: | Haiming Ma (Author), Guina Zhang (Author), Chunrong Mou (Author), Xiujuan Fu (Author), Yadan Chen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MORPHOMETRIC ANALYSIS OF THE GASTROINTESTINAL MUCOSA IN MONOSODIUM GLUTAMATE-TREATED ALBINO RATS
by: Numan AI, et al.
Published: (2010) -
Cortical Hypometabolism in West Syndrome
by: J Gordon Millichap
Published: (1997) -
Cortical Hypometabolism in West's Syndrome
by: J Gordon Millichap
Published: (1994) -
Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia
by: Changyu Pan, et al.
Published: (2011) -
Effect of monosodium glutamate on the growth of solanum melongena / Hafwanis Awang ... [et al.]
by: Awang, Hafwanis, et al.
Published: (2020)